Glucosamine modulates chondrocyte proliferation, matrix synthesis, and gene expression

Area of Science:

• Biochemistry
• Cell Biology
• Biomaterials Science

Background:

• Osteoarthritis (OA) is a degenerative joint disease characterized by cartilage breakdown.
• Glucosamine (GlcN) is a popular supplement for OA, but its precise biochemical effects on chondrocytes are not fully understood.
• Understanding GlcN's impact on chondrocytes is crucial for developing effective cartilage repair strategies.

Purpose of the Study:

• To investigate the effects of glucosamine (GlcN) on chondrocyte proliferation, matrix production, and gene expression.
• To elucidate the biochemical basis for GlcN's reported beneficial effects in osteoarthritis (OA).

Main Methods:

• Primary bovine chondrocytes were cultured in 2D monolayers and 3D hydrogel constructs.
• Dose-dependent effects of GlcN on cell morphology, proliferation, and matrix production were assessed.
• Gene expression, including transforming growth factor-beta1 (TGF-beta1), was analyzed using real-time PCR.

Main Results:

• GlcN concentration and culture conditions significantly influenced chondrocyte behavior.
• A specific GlcN concentration range (up to 2 mM) promoted cartilage matrix components (aggrecan, collagen type II) without compromising cell viability.
• GlcN treatment up-regulated TGF-beta1 mRNA levels, indicating a role in cellular signaling.

Conclusions:

• Culture conditions critically determine GlcN's effects on chondrocytes, explaining variable outcomes in previous studies.
• GlcN's modulation of TGF-beta1 signaling provides a biochemical mechanism for its chondrocyte activity.
• Optimal GlcN concentrations demonstrate an anabolic effect on chondrocytes, potentially aiding cartilage repair strategies.